Endothelin activation and postoperative renal failure after human liver transplantation

Liver Transplantation

Volumn 11, Issue 10, 2005, Pages 1201-1206

  Hetz, Hubert ^a   Bauer, Michael ^b   Lahner, Daniel ^a   Faybik, Peter ^a   Winning, Johannes ^b   Ankersmit, Hendrik Jan ^a   Bacher, Andreas ^a   Krenn, Claus Georg ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; LIVER TRANSPLANTATION; MALE; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RISK FACTOR; TREATMENT OUTCOME;

ENDOTHELINS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; TREATMENT FAILURE;

EID: 27244454916     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20477     Document Type: Article

References (50)

1. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-940.
2. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179-1185.
3. Sanchez EQ, Gonwa TA, Levy MF, Goldstein RM, Mai ML, Hays SR, et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation 2004;78:1048-1054.
4. Benigni A, Remuzzi G. Endothelin antagonists. Lancet 1999; 353:133-138.
5. Luscher TF, Barton M. Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 2000;102:2434-2440.
6. Naicker S, Bhoola KD. Endothelins: vasoactive modulators of renal function in health and disease. Pharmacol Ther 2001;90: 61-88.
7. Birck R, Knoll T, Braun C, Kirchengast M, Munter K, van der Woude FJ, Rohmeiss P. Improvement of postischemic acute renal failure with the novel orally active endothelin-A receptor antagonist LU 135252 in the rat. J Cardiovasc Pharmacol 1998; 32:80-86.
8. Kivlighn SD, Gabel RA, Siegl PK. Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction. Kidney Int 1994;45:131-136.
9. Heyman SN, Clark BA, Kaiser N, Spokes K, Rosen S, Brezis M, Epstein FH. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992;3:58-65.
10. Anand R, Harry D, Holt S, Milner P, Dashwood M, Goodier D, et al. Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut 2002;50:111-117.
11. Man K, Fan ST, Lo CM, Liu CL, Fung PC, Liang TB, et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 2003;237:256-264.
12. Shirakami G, Murakawa M, Shingu K, Mashima S, Suga S, Magaribuchi T, et al. Perioperative plasma concentrations of endothelin and natriuretic peptides in children undergoing living-related liver transplantation. Anesth Analg 1996;82:235-240.
13. Fabrega E, Figols J, Duenas C, Crespo J, Casafont F, Sanchez-Antolin G, et al. Value of endothelin in cellular rejection after liver transplantation. Clin Transplant 1997;11:25-28.
14. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988;85:9797-9800.
15. Schuller M. Investigations on renal and cardiac pathophysiological aspects of endothelin in man. PhD Dissertation. Vienna: University of Vienna; 1994.
16. Pacher R, Stanek B, Hulsmann M, Koller-Strametz J, Berger R, Schuller M, et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996;27:633-641.
17. Bauer M, Wilkens H, Langer F, Schneider SO, Lausberg H, Schafers HJ. Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation 2002;105:1034-1036.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130: 461-470.
19. Levey AS GT, Kusek JW, Beck GJ, MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000;11:155A.
20. Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004;10:301-309.
21. Sandok EK, Lerman A, Stingo AJ, Perrella MA, Gloviczki P, Burnett Jr JC. Endothelin in a model of acute ischemic renal dysfunction: modulating action of atrial natriuretic factor. J Am Soc Nephrol 1992;3:196-202.
22. Ruschitzka F, Shaw S, Gygi D, Noll G, Barton M, Luscher TF. Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1. J Am Soc Nephrol 1999;10:953-962.
23. Tomita K, Ujiie K, Nakanishi T, Tomura S, Matsuda O, Ando K, et al. Plasma endothelin levels in patients with acute renal failure. N Engl J Med 1989;321:1127.
24. Benigni A. Defining the role of endothelins in renal pathophysiology on the basis of selective and unselective endothelin receptor antagonist studies. Curr Opin Nephrol Hypertens 1995;4: 349-353.
25. Forbes JM, Hewitson TD, Becker GJ, Jones CL. Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function. Kidney Int 2001;59:1333-1341.
26. Rabelink TJ, Kaasjager KA, Boer P, Stroes EG, Braam B, Koomans HA. Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology. Kidney Int 1994;46:376-381.
27. Honing ML, Hijmering ML, Ballard DE, Yang YP, Padley RJ, Morrison PJ, Rabelink TJ. Selective ET(A) receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans. J Am Soc Nephrol 2000;11:1498-1504.
28. Textor SC, Wilson DJ, Lerman A, Romero JC, Burnett Jr JC, Wiesner R, et al. Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation. Transplantation 1992;54: 74-80.
29. Yokoi Y, Nakamura S, Serizawa A, Nishiyama R, Nishiwaki Y, Baba S. The role of endothelin in the pathophysiology of renal impairment during acute liver rejection. Transplantation 1994; 58:144-149.
30. Yokoyama I, Hayakawa A, Kobayashi T, Negita M, Hayashi S, Yasutomi M, et al. Endothelin-1 and in vitro evidence of renal artery vasoconstriction after liver transplantation. Res Exp Med (Berl) 1995;195:381-387.
31. Nakamura S, Nishiyama R, Serizawa A, Yokoi Y, Suzuki S, Konno H, et al. Hepatic release of endothelin-1 after warm ischemia. Reperfusion injury and its hemodynamic effect. Transplantation 1995;59:679-684.
32. Lopez-Farre A, Gomez-Garre D, Bernabeu F, Lopez-Novoa JM. A role for endothelin in the maintenance of post-ischaemic renal failure in the rat. J Physiol 1991;444:513-522.
33. Pagtalunan ME, Olson JL, Tilney NL, Meyer TW. Late consequences of acute ischemic injury to a solitary kidney. J Am Soc Nephrol 1999;10:366-373.
34. Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 1993;91:2144-2149.
35. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 1992;327:1774-1778.
36. Uchihara M, Izumi N, Sato C, Marumo F. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Hepatology 1992;16:95-99.
37. Asbert M, Gines A, Gines P, Jimenez W, Claria J, Salo J, et al. Circulating levels of endothelin in cirrhosis. Gastroenterology 1993;104:1485-1491.
38. Llado L, Ramos E, Figueras J, Serrano T, Torras J, Rafecas A, et al. Influence of endothelin-1 on hemodynamics during liver transplantation with and without temporary portocaval shunt: results of a clinical randomized study. Liver Transpl 2002;8:27-33.
39. Kapoor D, Redhead DN, Hayes PC, Webb DJ, Jalan R. Systemic and regional changes in plasma endothelin following transient increase in portal pressure. Liver Transpl 2003;9:32-39.
40. Fabrega E, Crespo J, Casafont F, de la Pena J, de Las Heras G, Amado JA, Pons-Romero F. Endothelin-1 and vascular complications in liver transplantation. Transplantation 1995;59:1748-1751.
41. Hemsen A, Ahlborg G, Ottosson-Seeberger A, Lundberg JM. Metabolism of big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21). Regul Pept 1995;55:287-297.
42. Tran Duc AT, Schwab AJ, Simard A, Villeneuve L, Dupuis J. Reduction in hepatic endothelin-1 clearance in cirrhosis. Clin Sci (Lond) 2003;105:227-234.
43. Gandhi CR, Kang Y, De Wolf A, Madariaga J, Aggarwal S, Scott V, Fung J. Altered endothelin homeostasis in patients undergoing liver transplantation. Liver Transpl Surg 1996;2:362-369.
44. Wait RB, Kahng KU. Renal failure complicating obstructive jaundice. Am J Surg 1989;157:256-263.
45. Kramer HJ, Schwarting K, Backer A, Meyer-Lehnert H. Renal endothelin system in obstructive jaundice: its role in impaired renal function of bile-duct ligated rats. Clin Sci (Lond) 1997;92: 579-585.
46. Nambi P, Pullen M, Wu HL, Prabhakar U, Hersh L, Gellai M. Down regulation of kidney neutral endopeptidase mRNA, protein and activity during acute renal failure: possible mechanism for ischemia-induced acute renal failure in rats? Mol Cell Biochem 1999;197:53-59.
47. Barton M, Shaw S, d'Uscio LV, Moreau P, Luscher TF. Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation. Biochem Biophys Res Commun 1997;238:861-865.
48. Cao Z, Cooper ME, Wu LL, Cox AJ, Jandeleit-Dahm K, Kelly DJ, Gilbert RE. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury. Hypertension 2000;36: 561-568.
49. Gellai M, Jugus M, Fletcher T, DeWolf R, Nambi P. Reversal of postischemic acute renal failure with a selective endothelin A receptor antagonist in the rat. J Clin Invest 1994;93:900-906.
50. Forbes JM, Jandeleit-Dahm K, Allen TJ, Hewitson TD, Becker GJ, Jones CL. Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure. Exp Nephrol 2001; 9:309-316.